$OCGN + 201% today

$OCGN a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, jump on $23M registered direct offering  yesterday night.

This gives to stock a BIG push today after the press release of last week where they announced a deal to co-develop a Covid-10 vaccine.

Here is the link of the press release of this morning and here is the one of the last week regarding the vaccine deal.

Here is the graph of the day.

Here is the 30 day overview.